致力于药物研发关键试剂的生产

15801534258
info@nebulabio.cn
产品名称 NebuSelect™ Recombinant Human PLAU/uPA (active form), His-tag
目录号 NBL-240980
别名 PLAU/uPA; PLAU; Urokinase; ATF; UPA; URK; u-PA; BDPLT5; QPD
外观 see COA
分子量 Ser21-Leu431
CAS N/A
溶解度 Water Soluble
存储条件 Short term 4℃; Long term -20℃.
保存时间 2 years
备注1 P00749-1
备注2
目录号 规格 价格 库存状态  
NBL-240980-100ug 100ug Inquire Inquire
NBL-240980-1mg 1mg Inquire Inquire
NBL-240980-Customized Size N/A Inquire Inquire


Product Name:

NebuSelect™ Recombinant Human PLAU/uPA (active form), His-tag


Catalog#:

NBL-240980


Description:

NebuSelect™ Recombinant Human PLAU/uPA (active form), His-tag(Cat#NBL-240980) is expressed in HEK293 with His tag at the C-Terminus.It contains Ser21-Leu431, which consists of two chains: Long chain A (Ser21-Phe177) and chain B (Ile179-Leu 431). The long chain A is further cleaved to yield a short chain A (Lys156-Phe 177) and N-Terminus fragment (Ser21-Lys155).


Species:

Human


Expression System:

HEK293


Molecular Weight: 

The protein has a predicted MW of 17.9 kDa (long chain A), 29.2 kDa (chain B) and 15.3 kDa (N-terminal fragment). The protein migrates to 30-38 kDa (chain B) and 17 kDa (N-terminal fragment) based on Bis-Tris PAGE result.


Target Name:

PLAU/uPA; PLAU; Urokinase; ATF; UPA; URK; u-PA; BDPLT5; QPD


Target Information:

Plasminogen activator, urokinase (uPA) is a secreted serine protease, cleaving the sequence Cys-Pro-Gly-Arg560-Val561-Val-Gly-Gly-Cys in plasminogen to form plasmin. Dysregulation of PLAU is often accompanied by various cancers and PLAU inhibition could suppress tumor growth. Collectively, PLAU is necessary for tumor progression and can be a diagnostic and prognostic biomarker in HNSCC.


Amino Acid Sequence: 

Ser21-Leu431


Purity:

>95%


Formulation:

see COA


Endotoxin:

<1EU/ug(LAL Method)


Storage: 

4°C for short term. 

-20°C for long term.


To get more information, please contact us freely.

相关产品